Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Deconvolution applied to the kinetics of extracorporal drug removal. Haemodialysis of cefsulodin

  • 24 Accesses

  • 5 Citations


A novel approach to the evaluation of the kinetics of drug removal by an extracorporal device (ECD), e.g., haemodialysis, haemofiltration, and haemoperfusion, is presented. The rate and extent of extracorporal drug removal (ECR) are determined by deconvolution. The proposed method is model independent in the sense that no specific models of corporal or extracorporal disposition are required. The estimation of various derived functions and parameters useful for describing ECR such as clearance and fractional drug removal are facilitated by the technique. The kinetics of cefsulodin elimination by haemodialysis in 3 patients were evaluated using the deconvolution approach. The results indicated that cefsulodin was dialyzable with ∼50% of the drug in the body removed by haemodialysis over 3–4 h.

This is a preview of subscription content, log in to check access.


  1. 1.

    Veng-Pedersen P (1980) Model-independent method of analyzing input in linear pharmacokinetic systems having polyexponential impulse response II: Numerical evaluation. J Pharm Sci 69: 305–312

  2. 2.

    Veng-Pedersen P (1981) Pharmacokinetic analysis by linear systems approach I: Cimetidine bioavailability and second peak phenomenon. J Pharm Sci 70: 32–38

  3. 3.

    Cutler DJ (1981) Assessment of rate and extent of drug absorption. Pharmacol Ther 14: 123–160

  4. 4.

    Cutler DJ (1978) Linear systems analysis in pharmacokinetics. J Pharmacokinet Biopharm 6: 265–282

  5. 5.

    Wolf AV, Remp DG, Kiley JE (1951) Artificial kidney function: Kinetics of hemodialysis. J Clin Invest 30: 1062–1070

  6. 6.

    Gibson TP, Nelson HA (1977) Drug kinetics and artificial kidneys. Clin Pharmacokinet 2: 403–426

  7. 7.

    Takki S, Gambertoglio JG, Honda DH, Tozer TN (1978) Pharmacokinetic evaluation of hemodialysis in acute drug over-dose. J Pharmacokinet Biopharm 6: 427–442

  8. 8.

    Gwilt PR, Perrier D (1978) Plasma protein binding and distribution characteristics of drugs as indices of hemodialyzability. Clin Pharmacol Ther 24: 154–161

  9. 9.

    Gwilt PR (1981) General equation for assessing drug removal by extracorporal devices. J Pharm Sci 70: 345–346

  10. 10.

    Lee C-SC (1982) The assessment of fractional drug removal by extracorporal dialysis. Biopharm Drug Dispos 3: 165–173

  11. 11.

    Gibson TP, Granneman GR, Kallal JE, Sennello LT (1982) Cefsulodin kinetics in renal impairment. Clin Pharmacol Ther 31: 602–608

  12. 12.

    Veng-Pedersen P (1977) Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT. J Pharmacokinet Biopharm 5: 513–531

  13. 13.

    Gillespie WR, Veng-Pedersen P (1985) A polyexponential deconvolution method. Evaluation of the “gastrointestinal bioavailability” and mean in vivo dissolution time of some ibuprofen dosage forms. J Pharmacokinet Biopharm 13: 289–307

  14. 14.

    Gillespie WR, Veng-Pedersen P (1985) Gastrointestinal bioavailability: in vivo release profiles of solid oral dosage forms by deconvolution. Biopharm Drug Dispos 6: 351–355

  15. 15.

    Veng-Pedersen P (1980) An algorithm and computer program for deconvolution in linear pharmacokinetics. J Pharmacokinet Biopharm 8: 463–481

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gillespie, W.R., Veng-Pedersen, P. & Gibson, T.P. Deconvolution applied to the kinetics of extracorporal drug removal. Haemodialysis of cefsulodin. Eur J Clin Pharmacol 29, 503–509 (1985). https://doi.org/10.1007/BF00613469

Download citation

Key words

  • deconvolution
  • haemodialysis
  • cefsulodin
  • extracorporal drug removal
  • pharmacokinetics